Navigation Links
Genetic-Key to Stop Heroin Addicts

Researchers from University of Adelaide in the Discipline of Pharmacology have found a genetic key for improving treatment success rates of heroin addicts around// the world. They have discovered a gene that helps determining the optimum methadone dosage levels for heroin addicts.

The study reveals why people are either less efficient or more effective in distributing drugs throughout their body to the central nervous system. It will allow people undergoing methadone treatment programs to be tested for the genetic variation to determine optimal treatment doses. The study results were published in journal Clinical Pharmacology and Therapeutics.

When the heroin addicts were tested, it was found that 25% of the people with a mutation of the gene can cope on lower doses of methadone. But the majority without the mutation process faster methadone, need almost double the amount to stave off heroin withdrawal.

It was also found that about 62% of drug addicts dropped out of methadone programs because of severe withdrawal symptoms.

Lead researcher and pharmacologist, Dr Janet Coller said "Individualised dosing may decrease the incidence of withdrawal symptoms in some people and therefore encourage them to continue with the methadone treatment" and added that “Accurate determination of methadone doses was essential to successfully treat users.”

This research is the first of its kind to investigate the problem of inaccurate dosing, which sees almost two out of every three of Australia's methadone users drop out of programs prematurely. Most fail in the first four weeks of the treatment, when the withdrawal effects are most severe. "It's entirely possible that the people who are failing are doing so because their genotype is such that they need more methadone than they're getting," says Dr Janet Coller. Dr Coller and her team tested 60 heroin addicts for the gene, called abcb1, and worked out whether they were getting the r
'"/>




Page: 1 2

Related medicine news :

1. Heroin to Treat Addiction
2. General Anesthesia For Heroin Detoxification Is No Good
3. Heroin Addicts Chained For Cure
4. Heroin Use May Reduce In Zurish, Study Says
5. Seizure of Low Quantity of Heroin is No Ground for Bail: HC
6. Heroin, Killed 130 People In US
7. Naloxone Prevents Heroin Overdose
8. Afghanistans double-edged problem - AIDS and Heroin
9. Prescription Opioids Abused More Than Heroin - A Report Says
10. Opioid Abuse More Prevalent than Heroin
11. Painkiller Dihydrocodeine May Replace Methodone In Treating Heroin Addicts
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Genetic Key Stop Heroin Addicts

(Date:7/25/2008)... New program delivers immediate co...[24-hour telephone access to language interpreters...g multilingual solutions. , ...LLE® http://www.lle-inc.com/index.html [(Lan...ider of interpretation, translation, and language ...
(Date:7/25/2008)... The Drug Information Association ...ill host the Critical Path Initiative (CPI) on the...16; Bethesda, MD) and the Critical Path Transporte... Horsham, PA (PRWEB) July 25...mation Association (DIA)] and the Food and Drug Ad...
(Date:7/24/2008)...TON-SALEM, N.C. Researchers at Wake Forest Unive...-standing clinical belief that the hepatitis C vir...restore itself after HIV patients are treated with..., Hepatitis C (HCV) infection is more serious in...e, according to the Centers for Disease Control. I...
(Date:7/24/2008)...UTH, Minn., July 24 /PRNewswire-FirstCall/ -- ev3 ... to report its 2008 second quarter and,year-to-dat...second quarter,and year-to-date financial results ...ding hours., The company will host a conference c...m. Eastern Time) on Tuesday, July 29, 2008. ev3,ma...
Breaking Medicine News(10 mins):Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2
...The Indian Prime Minister Dr Manmohan Singh has re... country with regard to generating vaccines which ... made this statement while inaugurating the third ...GAVI) Partners' meeting. The low cost vaccines pro...
...Mumbai lovers prefer the most crowded railway stat...it Narayanan, 27, hangs around with his girlfriend...ree times in a week and is happy about the venue. ...sily accessible place with lot of crowd moving up ...
...Bill Gates who was on a visit to India met our Hea...ussed about the development of vaccines against va...eet that they had discussed about many issues rega...his contributions. The vaccine program extends to...
...A fourth human case of bird flu infection has been...he Guangxi Zhuang Autonomous Region’s Ziyuan Count...0-year-old girl student surnamed Tang, who has bee...3 November 2005. The girl has tested positive for ...
Other Medicine News:Health News:India To Produce More Cost Effective Vaccines 2
(Date:7/22/2008)...s Including Lantus(R) and Apidra(R) Resulted in Si... 2 Diabetes, Whatever the Algorithm ...22 /- Results from the "Adjust to,Tar...orithm to Carbohydrate,Counting for Adjustment of ...in the American Diabetes Association,s (ADA) medic...
(Date:7/22/2008)... treatment with chemotherapy and pegylated enzyme ...ed to chemotherapy alone - - Pegy... /- Halozyme Therapeutics,... developing and,commercializing products targeting...sentation of positive pre-clinical animal efficacy...
(Date:7/22/2008)...IPOLIS, France, July 22 /- ...t has successfully completed the,enrollment of 417...rtension,in two clinical pharmacology studies in t...d timelines. These trials are designed to assess t...rison to ibuprofen and,naproxen, using the Ambulat...
(Date:7/21/2008)...ing to focus on use of Zevalin as consolidation th...reated patients with follicular ...re-FirstCall/ -- Cell Therapeutics, Inc.,(CTI) (Na...ny has scheduled,a meeting with the U.S. Food and ...the possibility of filing a supplemental Biologics...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4American Chemical Societys Weekly Presspac Sept 5 2007 853 1American Chemical Societys Weekly Presspac Sept 5 2007 853 2American Chemical Societys Weekly Presspac Sept 5 2007 853 3American Chemical Societys Weekly Presspac Sept 5 2007 853 4American Chemical Societys Weekly Presspac Sept 5 2007 853 5American Chemical Societys Weekly Presspac Sept 5 2007 853 6American Chemical Societys Weekly Presspac Sept 5 2007 853 7American Chemical Societys Weekly Presspac Sept 5 2007 853 8American Chemical Societys Weekly Presspac Sept 5 2007 853 9Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference 848 1Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference 848 2Biomoda Inc and Quintiles Announce Agreement for Regulatory Consulting 843 1Biomoda Inc and Quintiles Announce Agreement for Regulatory Consulting 843 2Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 450 1Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 450 2
...Closure of Multi-Center Trial in 4 Weeks Reinforce...s in Myeloma-, NORTH HOLLYWOOD, Calif., May 15, 20...ation (IMF) - supporting research and,providing ed...,families, researchers and physicians - today sai...enter myeloma trial using,REVLIMID(R) has demonstr...
... Poster Presented at Society for Investigative Der.../ -- AGI Dermatics,recently announced new comparat...cells have the ability to recognize, transport and...nst oxidative,damage, and importantly, that (EGT) ...than idebenone, scavenging reactive oxygen,species...
Other Medicine Technology:The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 2The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 3AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
... into the body more easily than any comparable sco...ching the lower pole calyces. Its smooth, lubricio...on of both scope and instruments. And its patented...us tip, and active secondary deflection deliver co...
...Ureteroscope permits direct visualization and acce... little or no dilation.,A tight bend radius and ...renal access, including the lower pole calyces. Du...reter and the renal pelvis. The 6.75 beveled tip f...
Smooth, contoured standard obturator provides less traumatic insertion through the urethra and into the bladder.
Electrohydraulic Lithotripsy Probe for AEH-4
Medicine Products: